Company / Return on Equity (ROE)
Sanara MedTech Inc. Return on Equity (ROE) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-162.8%
FY2025
5-year range
-162.8% / -10.9%
FY2021-FY2025
Trend
-1390.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Sanara MedTech Inc. reports negative total equity of -162.8% in FY2025. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-162.8% in FY2025 with a 5-year CAGR of -120.2%.
Declined from -17.7% to -162.8% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -143.8pp
- 5-Year Change
- -120.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 1390.4% year-over-year.
- Peak return on equity (roe) was recorded in FY2018.
- Lowest return on equity (roe) in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -162.8% | -1390.4% |
| FY2024 | -10.9% | +38.3% |
| FY2023 | -17.7% | +6.5% |
| FY2022 | -18.9% | -30.5% |
| FY2021 | -14.5% | +65.9% |
| FY2020 | -42.5% | -242.8% |
| FY2018 | 29.8% | +107.3% |
| FY2017 | -405.5% | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026